Ran, Xinru
Yang, Zhandong
Cheng, Li
Li, Weidong
Cui, Jieda
Huang, Peiyu
Wang, Zhongfang
Mao, Zhennan
Yi, Erkang
Tian, Yang
Li, Pan
Zhou, Yumin
Ran, Pixin
Guo, Feng
Funding for this research was provided by:
Young Scientists Program of Guangzhou Laboratory (QNPG23-18)
the Clinical and Epidemiological Research Project of State Key Laboratory of Respiratory Disease (SKLRD-L-202402)
Major Clinical Research Project of Guangzhou Medical University’s Scientific Research Capability Improvement Plan (GMUCR2024-01012)
the National Natural Science Foundation of China (82270043 and 82370051)
the Foundation of Guangzhou National Laboratory (GZNL2023A02001, GZNL2023A02002, SRPG22-018 and SRPG22-016)
Major Project of Guangzhou National Laboratory (GZNL2025C02006)
Article History
Received: 24 May 2025
Accepted: 9 December 2025
First Online: 5 January 2026
Declarations
:
: This human trial was approved by Medical Ethics Committee of the First Affiliated Hospital of Guangzhou Medical University (No. 2013–33). Written informed consent was obtained from all participants prior to enrollment, including consent for sample collection and use for research purposes. All procedures involving human participants were conducted in accordance with the principles of the Declaration of Helsinki.The animal study was approved by Laboratory Animal Ethics Committee of Guangzhou National Laboratory (No. GZLAB-AUCP-2022–09-A02).
: Not applicable.
: The authors declare no competing interests.